Top Stocks To Trade - Invest Million

Acceleron Pharma (NASDAQ: XLRN) Rockets On Successful Phase 2 Study For PAH Treatment

Acceleron Pharma Inc (NASDAQ: XLRN) was a top gainer in yesterday’s trading session, and closed the day with gains of 50.16%. This followed the company’s announcement that, its mid-stage study for Sotatercept, its treatment candidate for people with PAH (Pulmonary Arterial

Financial

Concert Pharmaceuticals (NASDAQ: CNCE) Rallies After Getting Notice Of Allowance From The US Patent And Trademark Office

Concert Pharmaceuticals Inc. (NASDAQ: CNCE) was a top gainer in yesterday’s trading session. The stock edged higher to close the day with gains of 33.03%. This came after the company announced that, it had got a notice of allowance from the U.

NASDAQ: MESO

Mesoblast Limited (NASDAQ: MESO) Surges Higher After Presentation At The 2020 Biotech Show In San Francisco

Mesoblast Limited (NASDAQ: MESO) was in the green on Friday, and closed the day with gains of 13%. This came after the company did a presentation for its commercial plans at the 2020 biotech show in San Francisco. In the presentation, the company

NASDAQ Small Cap

Cemtrex Inc (NASDAQ: CETX) Rallies After Receiving A $700k Video Surveillance Equipment Order

Cemtrex Inc (NASDAQ: CETX) opened yesterday’s session with a gap up, and closed the day with gains of 54.24%. This happened after the company made a press release announcing that, it had received an order of more than $700k for advanced equipment.

Breaking News

Adaptimmune Therapeutics PLC (NASDAQ: ADAP) Up By 200% After Announcing Partnership Agreement With Astellas

Adaptimmune Therapeutics Plc (NASDAQ: ADAP) was one of the top gainers in yesterday’s trading session, and closed with gains of 200%. This came after the company announced that, it had entered into an agreement with Astellas for the development and commercialization of allogeneic

Financial

Apellis Pharmaceuticals (NASDAQ: APLS) Trades Up On Positive Phase 3 PEGASUS Results and Public Stock Offer News

Apellis Pharmaceuticals Inc (NASDAQ: APLS) made significant gains in yesterday’s trading session, as it closed the day with gains of 28.29%. This followed several major announcements both in science and finance. On the scientific front, the company announced that it had positive

Investments

Catalyst Biosciences Inc (NASDAQ: CBIO) Rallies After Announcing Global Collaboration With Biogen Inc

Catalyst BioSciences Inc (NASDAQ: CBIO) was one of the top gainers in yesterday’s trading session, and closed the day with gains of 65.83%. This came after it announced that, it had entered into a global license and collaboration with Biogen Inc.

NASDAQ: ONCY

Oncolytics Biotech (NASDAQ: ONCY) Sustains Gains Days After Positive News on Pelareorep, a Treatment For Solid Tumors

Oncolytics Biotech Inc (NASDAQ: ONCY) was a big gainer in Tuesday’s trading session, and closed the day with gains of 34.33%. This came a few days after the company announced acceptance of an abstract for a potential new biomarker data from the

Gaining Stocks NYSE

IsoRay Inc (NYSE: ISR) Rallies as It Strengthens Leadership in the Prostate Brachytherapy Market

IsoRay Inc (NYSE: ISR) has been gaining upside momentum ever since it announced Q1 results for the fiscal year 2020. The company announced that it had a quarterly EPS loss of $0.01, much lower than analyst expectations of a loss of $0.02.

Gaining Stocks

Molecular Templates (NASDAQ: MTEM) Charges Forward on Funding News

Molecular Templates Inc (NASDAQ: MTEM) was one of the biggest gainers at the close of the week. On Friday, the stock rallied by 17.07% to close the week at $13.03. This followed news that the company had entered into a funding agreement

Breaking News

Can-Fite Biopharma Ltd (NYSE: CANF) Rallies on Positive News about Liver Cancer Treatment

Can-Fite Biopharma Ltd (NYSE: CANF) has been gaining steadily for the last few days. At the time of writing, the stock is up by 31.12% to trade at $3.36. Its upside momentum is driven by positive sentiment after it announced Q3 results.

Breaking News

Chemocetryx Inc (NASDAQ: CCXI) Rallies By Over 200% As Trial Treatment Shows Potential

ChemoCentryx Inc (NASDAQ: CCXI) was one of the biggest gainers in Tuesday’s trading session. The stock shot up by 281.27% to close the day at $30.73. This followed news that the company’s treatment candidate showed potential in the treatment of